CanFlow Global
← All insights
controlled-substancescbsa-enforcementcfiaimport-complianceprecursor-chemicals

Three New Controlled Substances Hit Import Watch Lists June 5

Health Canada scheduled three substances — spirobrorphine, spirochlorphine, and R 29676 — as temporary controls starting June 5, 2026. For brokers and importers, that means documentation scrutiny, CFIA referrals, and exam risk on anything touching pharma precursors or synthetic inputs.

What Changed

Health Canada issued a one-year temporary control order on three substances: spirobrorphine, spirochlorphine (both synthetic opioids), and R 29676, a precursor chemical. The order takes effect June 5, 2026, under the Controlled Drugs and Substances Act. All three are flagged as high-risk imports linked to criminal supply chains.

For importers bringing in pharmaceutical intermediates, research chemicals, or any raw material that might touch a precursor schedule, this is the kind of notice that turns a routine PARS release into a three-day exam and a phone call from CFIA.

Where It Lands on Your CAD

Controlled substances live in a different filing universe. You’re not just classifying HS and claiming origin. You’re documenting end-use, registering the importer with Health Canada if they aren’t already, and proving the shipment isn’t subject goods under the Controlled Drugs and Substances Act. CBSA will refer the entry to CFIA, and CFIA doesn’t release until they see the paperwork.

If your supplier ships a chemical that’s a known precursor or a structural analog of something on the controlled list, expect:

  • Mandatory examination, not random.
  • A hold until CFIA clears the consignment.
  • A requirement for an import permit if the substance is scheduled (even temporarily).
  • Possible detention if your broker can’t produce end-use documentation or importer registration on file.

The one-year control period means this isn’t permanent scheduling yet, but enforcement is live. CBSA will treat these three substances the same way they treat fentanyl analogs or carfentanil precursors: guilty until proven otherwise.

What Triggers the Flag

CBSA doesn’t wait for you to declare something as controlled. They screen on:

  • HS classification (Chapter 29 for organic chemicals, 30 for pharma, sometimes 38 for chemical preparations).
  • Country of origin and known manufacturing hubs for precursor chemicals.
  • Shipper name and FIRMS code history.
  • Declared product descriptions that use vague language: “research chemical,” “industrial intermediate,” “fine chemical for further processing.”

If you’re importing anything that even rhymes with a synthetic opioid precursor, CBSA’s targeting system will pull the shipment. You’ll get a referral notice, and your release timeline just added 48 to 72 hours minimum.

The Importer’s Homework

If you’re bringing in chemicals that could overlap with the new schedule, your broker needs three things before the shipment clears:

  1. A clear end-use declaration. Who’s the consignee? What’s the substance used for? If it’s pharma manufacturing, lab research, or industrial synthesis, document it. CFIA won’t accept “commercial use” as an answer.
  2. Importer registration. If your client isn’t registered with Health Canada’s controlled substances program, they can’t import scheduled goods. Period. Registration takes weeks, not days, so this isn’t something you fix at the border.
  3. Product specification sheets. Chemical name, CAS number, purity, and a data sheet from the supplier. CFIA will compare what’s declared on the CAD to what’s in the container. If they don’t match, the shipment gets held pending lab analysis.

We handle precursor imports regularly, and the pattern is consistent: the shipments that clear fast are the ones where the importer already has the documentation queued up before the container lands. The ones that sit for a week are the ones where the client thought “chemical precursor” was just a line on the commercial invoice.

CBSA’s enforcement priorities are published, but the operational reality is that controlled substance referrals don’t get released on RMD or release prior to payment. You’re filing a full CAD, waiting for CFIA clearance, and paying any exam fees if CBSA opens the container.

Exam Risk and Cost

If CBSA flags your shipment for examination, you’re looking at:

  • Exam fees (typically a few hundred dollars, depending on the service area and whether it’s a full unload or a sample pull).
  • Dwell time at the sufferance warehouse while CBSA schedules the exam and CFIA reviews the file.
  • Possible demurrage or detention if the container is still on chassis or if the exam delay pushes you past port free time.

For Montreal imports, our sufferance warehouse handles CBSA exams daily, and we’ve seen precursor chemical exams take anywhere from same-day clearance (when documentation is clean) to five business days (when CFIA sends samples to the lab). The exam itself is quick. The wait for the lab report isn’t.

If you’re importing controlled or precursor substances and you don’t have a release strategy that accounts for CFIA holds, your dwell cost will eat any savings you thought you got on FOB pricing.

What Changes June 5

Before June 5, spirobrorphine, spirochlorphine, and R 29676 were unscheduled. A shipment might get flagged on general risk targeting, but there was no automatic control.

After June 5, any import of these three substances requires the same documentation and clearance process as any other scheduled controlled substance. If your supplier ships one of these chemicals without telling you, your container is getting examined, and your importer is getting a compliance letter from CFIA.

The temporary scheduling period is one year. If these substances prove to be a persistent enforcement problem, Health Canada will move them to permanent scheduling. If they don’t, the order expires and the substances revert to unscheduled status. Either way, for the next twelve months, treat them as high-risk.

Where Compliance Actually Sits

Most importers don’t know they’re importing a precursor chemical until CBSA tells them. The supplier calls it an “industrial intermediate” or “research reagent,” and the product description on the invoice is generic enough that it doesn’t trigger internal flags.

That’s fine until it isn’t. The fix is upstream: when you onboard a new chemical supplier, especially one shipping from a known precursor manufacturing region, run the product list past your broker. We can’t tell you whether a chemical is controlled without a CAS number and a spec sheet, but we can tell you whether the HS classification and product description are going to trigger a referral.

If you’re importing anything in HS Chapter 29 or 38 that’s described as a synthetic intermediate, a fine chemical, or a pharmaceutical precursor, talk to us before the shipment moves. Fixing the documentation after CBSA issues a hold notice is possible, but it’s slower and more expensive than getting it right on the first CAD.

We file CADs against controlled substance shipments every month. The ones that clear without drama are the ones where the importer knew what they were buying and had the paperwork ready. If your supplier just added one of these three chemicals to your inbound mix, now’s the time to ask questions. Get in touch.

Source: CSCB

Talk to a broker